Ghent University Academic Bibliography

Journal Article
A1
open access

Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach?

Mathieu Spaas (UGent) and Yolande Lievens (UGent)

(2019) FRONTIERS IN MEDICINE. 6.

Oligometastatic prostate cancer : the game is afoot

Andrea Lancia, Thomas Zilli, Verane Achard, Piet Dirix, Wouter Everaerts, Alfonso Gomez-Iturriaga, Gianluca Ingrosso, Nick Liefhooghe, Raymond Miralbell, Shankar Siva, et al.

(2019) CANCER TREATMENT REVIEWS. 73. p.84-90

Add to list

Combined modality treatment for malignant pleural mesothelioma : a single-centre long-term survival analysis using extrapleural pneumonectomy

Anna Elisabeth Frick, Kristiaan Nackaerts, Johnny Moons, Yolande Lievens (UGent) , Eric Verbeken, Maarten Lambrecht, Johan Coolen, Christophe Dooms, Johan Vansteenkiste, Paul De Leyn, et al.

(2019) EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 55(5). p.934-341

Add to list

Fibroblasts fuel immune escape in the tumor microenvironment

Emiel De Jaeghere (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2019) TRENDS IN CANCER. 5(11). p.704-723

Add to list

Developments and future clinical outlook of taxane nanomedicines

Benoit Louage (UGent) , Olivier De Wever (UGent) , Wim E Hennink and Bruno De Geest (UGent)

(2017) JOURNAL OF CONTROLLED RELEASE. 253. p.137-152

Add to list

Emerging role of the unfolded protein response in tumor immunosurveillance

Hélène Vanacker, Jessica Vetters (UGent) , Lyvia Moudombi, Christophe Caux, Sophie Janssens (UGent) and Marie-Cécile Michallet

(2017) TRENDS IN CANCER. 3(7). p.491-505

Add to list

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Ahmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van Der Heyden (UGent) , Tony Lahoutte, Jan Tavernier (UGent) and Nick Devoogdt

(2017) MOLECULAR CANCER THERAPEUTICS. 16(12). p.2828-2839

Add to list

Exploration of the medicinal peptide space

Bert Gevaert (UGent) , Sofie Stalmans (UGent) , Evelien Wynendaele (UGent) , Lien Taevernier (UGent) , Nathalie Bracke (UGent) , Matthias D'Hondt and Bart De Spiegeleer (UGent)

(2016) PROTEIN AND PEPTIDE LETTERS. 23(4). p.324-335

Add to list

Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations

Daan Joost De Maeseneer, Charles Van Praet (UGent) , Nicolaas Lumen (UGent) and Sylvie Rottey (UGent)

(2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(7). p.310-321

Add to list

Journal Article
A1
open access

Second line therapy in malignant pleural mesothelioma: a systematic review

Wieneke A Buikhuisen, Birgitta I Hiddingab, Paul Baas and Jan Van Meerbeeck (UGent)

(2015) LUNG CANCER. 89(3). p.223-231

Academic Bibliography

Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach?

Oligometastatic prostate cancer : the game is afoot

Combined modality treatment for malignant pleural mesothelioma : a single-centre long-term survival analysis using extrapleural pneumonectomy

Fibroblasts fuel immune escape in the tumor microenvironment

Developments and future clinical outlook of taxane nanomedicines

Emerging role of the unfolded protein response in tumor immunosurveillance

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Exploration of the medicinal peptide space

Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations

Second line therapy in malignant pleural mesothelioma: a systematic review

Contents

Support

Contact